Antimicrobial resistance (AMR) is one of the most pressing public health threats we will face in our lifetimes. In fact, in 2019, almost 5 million deaths worldwide were associated with bacterial AMR, with this number only growing. In this feature, we take a look at the State Of the bacterial AMR field, looking at the past, the present and the...

With the ever-increasing potential of new technology and the exponential growth of the life sciences field, researchers are always running into new problems to solve. In this interview series, we get scientists’ opinions on the ‘Big Challenge’ in their field and the steps being taken to address it. From new and unique hurdles to fresh...

Multi-omics is rapidly becoming one of the most influential methods in the life sciences, poised to become the cornerstone technique of future research.   In these early stages of progress, clear and informative dialogue between experts in the field is vital. No one has the time to read all the papers and preprints necessary to truly ‘stay...

It’s that time of the week again – check out the latest stories from the genomics world and beyond in Week in Brief. Promising clinical trial results have been published this week, bringing the reality of genomic and personalised medicine closer for many individuals… Following positive Phase 2 results, a Phase 3 clinical trial...

The use of genomics in drug discovery has been heralded as a revolutionary tool. With most drugs ultimately failing at some point in the pipeline, and an investment of 10-15 years and billions of dollars into those that do eventually make the cut, it has been suggested that the integration genomic data could potentially double the likelihood of a drug...

What’s been going on in the genomics world in the last seven days? In Week in Brief, we’ve got the answers for you! Efforts have been made to develop non-invasive tests for various illnesses… Scientists have discovered a biomarker that could predict acute cellular rejection after organ transplants. The biomarker could become the...